CSPC Pharmaceutical Group Limited (CHJTF)

USD 0.64

(0.0%)

Total Liabilities Summary of CSPC Pharmaceutical Group Limited

  • CSPC Pharmaceutical Group Limited's latest annual total liabilities in 2023 was 1.53 Billion USD , up 8.69% from previous year.
  • CSPC Pharmaceutical Group Limited's latest quarterly total liabilities in 2024 Q1 was -4.84 Billion USD , down -414.96% from previous quarter.
  • CSPC Pharmaceutical Group Limited reported annual total liabilities of 1.41 Billion USD in 2022, up 17.86% from previous year.
  • CSPC Pharmaceutical Group Limited reported annual total liabilities of 1.2 Billion USD in 2021, up 17.06% from previous year.
  • CSPC Pharmaceutical Group Limited reported quarterly total liabilities of -4.84 Billion USD for 2024 Q1, down -414.96% from previous quarter.
  • CSPC Pharmaceutical Group Limited reported quarterly total liabilities of - USD for 2023 Q3, down -100.0% from previous quarter.

Annual Total Liabilities Chart of CSPC Pharmaceutical Group Limited (2023 - 2015)

Historical Annual Total Liabilities of CSPC Pharmaceutical Group Limited (2023 - 2015)

Year Total Liabilities Total Liabilities Growth
2023 1.53 Billion USD 8.69%
2022 1.41 Billion USD 17.86%
2021 1.2 Billion USD 17.06%
2020 1.02 Billion USD 7.63%
2019 954.02 Million USD -12.42%
2018 1.08 Billion USD 43.08%
2017 761.29 Million USD 34.33%
2016 566.72 Million USD -3.29%
2015 585.99 Million USD 0.0%

Peer Total Liabilities Comparison of CSPC Pharmaceutical Group Limited

Name Total Liabilities Total Liabilities Difference
AstraZeneca PLC 61.86 Billion USD 97.511%
Bristol-Myers Squibb Company PFD CONV 2 65.67 Billion USD 97.655%
Clarus Therapeutics Holdings, Inc. 67.62 Million USD -2176.921%
Novartis AG 53.19 Billion USD 97.105%
PT Kalbe Farma Tbk. 255.94 Million USD -501.63%